(Q40036198)

16 September 2017

title

Development of an adenoviral vector with robust expression driven by p53. (English)

1 reference

16 September 2017

1 reference

2

1 reference

16 September 2017

Marcio C Bajgelman

1

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

16 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

16 September 2017

volume

371

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

8-13

1 reference

The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Exploration of critical parameters for transient retrovirus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Oncogenic forms of p53 inhibit p53-regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Targeting gene-virotherapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Isolation of Temperature-sensitive p53 Mutations from a Comprehensive Missense Mutation Library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Mutant p53: an oncogenic transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

pCLPG: a p53-driven retroviral system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

Suicide gene therapy on LNCaP human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

A temperature-sensitive mutant of human p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

A luciferase-engineered cell line for study of cAMP regulation in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.11.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2007.11.015

1 reference

16 September 2017

1 reference